Lenalidomide [lenalidomid]
topical
145
- Terms
-
Revimid
-
2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
CC 5013
CC-5013
CC5013
IMiD3 Cpd
Revimid
Revlimid
Persistent link
https://www.medvik.cz/link/D000077269
Definition
A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
- DUI
- D000077269 MeSH Browser
- CUI
- M0479831
- History note
- 2019 (2002)
- Public note
- 2019; LENALIDOMIDE was indexed under THALIDOMIDE/analogs & derivatives 2002-2018
Allowable subheadings
- AD
- administration & dosage 33
- AE
- adverse effects 21
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 17
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 64
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records